Browse > Article
http://dx.doi.org/10.7314/APJCP.2012.13.9.4441

Meta-analysis of the Relation Between the VDR Gene TaqIpolymorphism and Genetic Susceptibility to Prostate Cancer in Asian Populations  

Guo, Ya-Jie (College of Materials and Chemistry & Chemical Engineering, Chengdu University of Technology)
Shi, Ze-Ming (College of Materials and Chemistry & Chemical Engineering, Chengdu University of Technology)
Liu, Jun-Da (College of Materials and Chemistry & Chemical Engineering, Chengdu University of Technology)
Lei, Ning (College of Materials and Chemistry & Chemical Engineering, Chengdu University of Technology)
Chen, Qiu-Hong (College of Materials and Chemistry & Chemical Engineering, Chengdu University of Technology)
Tang, Ying (College of Materials and Chemistry & Chemical Engineering, Chengdu University of Technology)
Publication Information
Asian Pacific Journal of Cancer Prevention / v.13, no.9, 2012 , pp. 4441-4444 More about this Journal
Abstract
Background: Polymorphisms of the Taq I gene have been associated with prostate cancer risk. Methods:We applied a fixed-effects model to combine odds ratios (ORs) and 95% confidence intervals (95% CI). The Egger's test was carried out to evaluate potential publication bias. Results: A total of 10 case-control studies enrolling 1,141 prostate cancer patients and 1,685 controls were included in this meta-analysis. Compared with the T allele, the OR for the C allele was 0.81 (0.70-0.94). The ORs for CT and CC+CT genotypes were 0.86 (0.74-1.01) and 0.84 (0.73-0.97) compared to wide type genotype (homozygote TT). Conclusions: The present meta-analysis suggests that the TF gene Taq I polymorphism may reduce the prostate cancer risk in Asian populations.
Keywords
Vitamin D receptor; Taq I; prostate cancer; Asian populations; meta-analysis;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Bao BY, Yeh SD, Lee YF (2006). 1alpha,25-dihydroxyvitamin D3 inhibits prostate cancer cell invasion via modulation of selective proteases.Carcinogenesis, 27, 32-42.
2 Bai Y, Yu Y, Yu B, et al (2009). Association of vitamin D receptor polymorphisms with the risk of prostate cancer in the Han population of Southern China. BMC Med Genet, 10, 125.
3 Bid HK, Mishra DK, Mittal RD (2005). Vitamin-D receptor (VDR) gene (Fok-I, Taq-I and Apa-I) polymorphisms in healthy individuals from north Indian population. Asian Pac J Cancer Pre, 6, 147-52.
4 Campbell MJ, Elstner E, Holden S, et al (1997). Inhibition of proliferation of prostate cancer cells by a 19-nor-hexafluoride vitamin D3 analogue involves the induction of p21waf1, p27kip1 and Ecadherin. J Mol Endocrinol, 19, 15-27.   DOI
5 Cariati F, Negri A, Pivonello C, et al (2012). Vitamin D from genetics to the clinical in prostate cancer. Endocrine Abstracts, 29, P836.
6 Chaimuangraj S, Thammachoti R, Ongphiphadhanakul B, et al (2006). Lack of association of VDR polymorphisms with Thai prostate cancer as compared with benign prostate hyperplasia and controls. Asian Pac J Cancer Prev, 7, 136-9.
7 Corder EH, Guess HA, Hulka BS et al (1993).Vitamin D and prostate cancer: a prediagnostic study with stored sera. Cancer Epidemiol Biomarkers Prev, 2, 467-72.
8 Dersimonian R, Laird N (1986). Meta-analysis in clinical trials. Control Clin Trials, 7, 177-88.   DOI
9 Habuchi T, Suzuki T, Sasaki R, et al (2000). Association of vitamin D receptor gene polymorphism with prostate cancer and benign prostatic hyperplasia in a Japanese population. Cancer Res, 60, 305-8.
10 Hamasaki T, Inatomi H, Katoh T, et al (2001).Clinical and pathological significance of vitamin D receptor gene polymorphism for prostate cancer which is associated with a higher mortality in Japanese. Endocr J, 48, 543-9.   DOI
11 Hamasaki T, Inatomi H, Katoh T, et al (2002). Significance of vitamin D receptor gene polymorphism for risk and disease severity of prostate cancer and benign prostatic hyperplasia in Japanese. Urol Int, 68, 226-31.   DOI   ScienceOn
12 Hidalgo AA, Paredes R, Garcia VM, et al (2007). Altered VDRmediated transcriptional activity in prostate cancer stroma. J Steroid Biochem Mol Biol, 103, 731-6.   DOI
13 Huang SP, Chou YH, Wayne Chang WS, et al (2004).Association between vitamin D receptor polymorphisms and prostate cancer risk in a Taiwanese population. Cancer Lett, 207, 69-77.   DOI
14 Jemal A, Siegel R, Ward E, et al (2009). Cancer statistics, 2009. CA Cancer J Clin, 59, 225-49.   DOI   ScienceOn
15 Jose S, George PS, Mathew A (2008). Assessment of confounding and interaction using the mantel-haenszel risk estimation method. Asian Pac J Cancer Prev, 9, 323-5.
16 Krishnan AV, Peehl DM, Feldman D (2003). Inhibition of prostate cancer growth by vitamin D: Regulation of target gene expression. J Cell Biochem, 88, 363-71.   DOI
17 Li M, Zhang S, Ma J, et al (2009). A comparative study on incidence trends of prostate cancer in part of cities and counties in China. Chin J Urol, 30, 368-70. (article in China)
18 Liu J, Li H, Gu L, et al (2004a). Association between VDRG 3' polymorphisms and prostate cancer in Chinese population. Chin J Clin Rehab, 8, 3429-32. (article in China)
19 Liu J, Li H, Tong M, et al (2004b). Susceptibility gene polymorphism and risk of prostate cancer in Chinese population. Nat Med J China, 84, 364-8. (article in China)
20 Moon SJ, Fryer AA, Strange RC (2005). Ultraviolet radiation: effects on risks of prostate cancer and other internal cancers. Mutat Res, 571, 207-19.   DOI
21 Onsory K, Sobti RC, Al-Badran AI, et al (2008). Hormone receptor-related gene polymorphisms and prostate cancer risk in North Indian population.Mol Cell Biochem,314,25-35.   DOI
22 Schaid DJ(2004).The complex genetic epidemiology of prostate cancer. Hum Mol Genet, 13, R103-21.   DOI
23 Schwartz GG (2012). Circulating vitamin D and risk of prostate cancer--letter. Cancer Epidemiol Biomarkers Prev, 21, 246.   DOI
24 Schwartz GG, Hulka BS (1990). Is vitamin D deficiency a risk factor for prostate cancer? (Hypothesis). Anticancer Res, 10, 1307-11.
25 Suzuki K, Matsui H, Ohtake N, et al (2003).Vitamin D receptor gene polymorphism in familial prostate cancer in a Japanese population. Int J Urol, 10, 261-6.   DOI
26 Vieira AR (2006). Association between the transforming growth factor alpha gene and nonsyndromic oral clefts: a HuGE review. Am J Epidemiol, 163, 790-810.   DOI
27 Watanabe M, Fukutome K, Murata M, et al (1999).Significance of vitamin D receptor gene polymorphism for prostate cancer risk in Japanese. Anticancer Res, 19, 4511-4.
28 Williamson PR, Gamble C, Altman DG, et al (2005). Outcome selection bias in meta-analysis. Stat Methods Med Res, 14, 515-24.   DOI
29 Ylikomi T, Laaksi I, Lou YR, et al (2002).Antiproliferative action of vitamin D. Vitam Horm, 64, 357-406.   DOI
30 Zhang WB, Zhang JH, Pan ZQ, et al (2012). The MTHFR C677T Polymorphism and Prostate Cancer Risk: New Findings from a Meta-analysis of 7306 Cases and 8062 Controls. Asian Pac J Cancer Prev, 13, 2597-604.   DOI
31 Zmuda JM, Cauley JA, Ferrell RE (2000).Molecular epidemiology of vitamin D receptor gene variants. Epidemiol Rev, 22, 203-17.   DOI